Adage Capital Partners Gp, L.L.C. Innate Pharma Sa Transaction History

Adage Capital Partners Gp, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$3.77 - $6.55 $1.89 Million - $3.28 Million	-500,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.8 - $7.95 $1.14 Million - $2.39 Million	300,000 Added 150.0%	500,000 $3.34 Million
Q4 2019 Feb 14, 2020	BUY	$5.66 - $6.55 $1.13 Million - $1.31 Million	200,000 New	200,000 $1.29 Million

242K

Ticker IPHA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,893,000
Market Cap $183M
Description
Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.